You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
L’ORÉAL FINANCIAL HIGHLIGHTS<br />
CONSOLIDATED SALES<br />
(€ millions)<br />
CONSOLIDATED SALES BY BRANCH (2) IN <strong>2008</strong><br />
06<br />
17,542<br />
17,063<br />
15,790<br />
14,533<br />
13,641<br />
2004<br />
2005<br />
€ millions<br />
2006<br />
2007<br />
<strong>2008</strong><br />
Growth<br />
Like-for-like Published figures<br />
Cosmetics 16,359 +2.7% +2.8%<br />
The Body Shop 756 +4.6% –3.9%<br />
Dermatology (3) 427 +17.1% +16.2%<br />
BREAKDOWN OF SHAREHOLDING STRUCTURE<br />
AT DECEMBER 31 st , <strong>2008</strong><br />
30.8%<br />
Mrs Bettencourt<br />
and her family<br />
29.6%<br />
Nestlé<br />
NET PROFIT EXCLUDING NON-RECURRENT ITEMS<br />
AFTER MINORITY INTERESTS (4)<br />
(€ millions)<br />
1,639<br />
1,486<br />
(1) In accordance with the law, treasury stock carries no voting rights.<br />
(2) The group business is composed of the cosmetics and dermatology branches and The Body Shop.<br />
(3) Group share, i.e. 50%.<br />
(4) Non-recurrent items include capital gains and losses on long-term asset disposals, depreciation of long-term assets and restructuring costs.<br />
(5) For comparison purposes, 2004 pro forma profit and loss accounts are restated in order to reflect the deconsolidation of Sanofi-Synthélabo at January 1 st , 2004:<br />
– by replacing the share in net income of Sanofi-Synthélabo, €293.5 million, by the received dividends, €145.9 million,<br />
– and by neutralizing the net of tax dilution capital gain relating to these shares, €2,854.5 million before any deduction and €471.1 million of taxes.<br />
2004 (5)<br />
2005<br />
1,833<br />
2006<br />
2,039<br />
2007<br />
2,064<br />
<strong>2008</strong><br />
36.4%<br />
Public<br />
3.2%<br />
Treasury<br />
stock (1)
Change language